SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arrowhead Resarch
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
172 20 0 ARWR
Emcee:  mikehunt2 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
122Given the market reaction, this is obviously big news.Glenn Petersen13/22/2010
121Arrowhead Research Subsidiary, Calando Pharmaceuticals, Provides First Proof of mikehunt223/22/2010
120ARWR--- Long shareszx-2/19/2010
119Arrowhead's Portfolio Company, Nanotope, Publishes Preclinical Data Demonstrmikehunt2-2/2/2010
118Unidym Announces Joint Venture to Market Printable CNT Electronics in Korea SUmikehunt2-2/1/2010
117Unidym Completes Licensing Agreements to Expand Use of its Carbon Nanotube IP inmikehunt2-1/20/2010
116Tego Biosciences is acquired by Luna Innovations ROANOKE, Va., Dec 29, 2009 (BUmikehunt2-12/29/2009
115Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio tomikehunt2-12/28/2009
114Arrowhead Subsidiary, Unidym, Enters into Joint Development Agreement with a Majmikehunt2-12/14/2009
113Unidym and Nano-C Enter Exclusive License Agreement for Fullerene Derivatives Usmikehunt2-12/2/2009
112Arrowhead Subsidiary Unidym, Inc. Enters into Third Year of Joint Development Prmikehunt2-11/11/2009
111Arrowhead CEO Provides Update on Company Strategy and Operations PASADENA, Calimikehunt2-11/3/2009
110Looks good at first glance. What's your take?The Ox-6/23/2009
109Arrowhead Subsidiary Calando Pharmaceuticals Enters into License Agreement with mikehunt2-6/23/2009
108Arrowhead Subsidiary Unidym Establishes Partnership with Continental Carbon Compmikehunt2-5/11/2009
107Calando Pharmaceuticals Publishes New Results of siRNA Delivery Using Its RONDELmikehunt2-12/8/2008
106Arrowhead Research (NASDAQ: ARWR) Subsidiary, Calando Pharmaceuticals, Inc., Feamikehunt2-12/5/2008
105November 18, 2008 Nanotech Touch-Screens Could Make You Historic Returns I noticmikehunt2-11/19/2008
104Mike, I noticed the large institutional ownership of stock in ARWR with FidelityCosmo Daisey-11/19/2008
103Arrowhead CEO Provides Update on Tego Biosciences Corporation Wednesday Novembermikehunt2-11/19/2008
102Arrowhead CEO Provides Update on Nanotope, Inc. Wednesday November 12, 7:00 am Emikehunt2-11/12/2008
101Arrowhead CEO Provides Update on Majority Owned Subsidiary Unidym, Inc. Tuesday mikehunt2-11/4/2008
100Arrowhead CEO Provides Update on Wholly Owned Subsidiary Agonn Systems, Inc. Tuemikehunt2-10/28/2008
99Unidym Lauds Samsung Electronics' Demo of Color Carbon Nanotube-Based Electrmikehunt2-10/27/2008
98Arrowhead Considering Selling Subsidiary Calando to Cash In On Delivery Technolmikehunt2-10/24/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News